Unichem Laboratories sale its stake in Optimus Drugs
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
SK Capital’s investment will serve as a catalyst for a new strategic direction as the Company seeks to deepen and expand its presence in fine chemistries for the global life science market.
The company shall be engaged in the business of manufacturing of pharmaceutical, bio-pharmaceutical and biological products of any kind
A special purpose vehicle (SPV) formed by O2 Energy SG Pte Ltd, for generation and supply of renewable power
The drive also conducted a mega health camp, cancer screening for women and men, ENT screening for children, and blood donation drive
Fund VI will focus on investments in industrials and healthcare businesses with proven technologies and solutions positioned to deliver high performance and value-add to their customers
Collaboration supports multiple discovery efforts, including vaccines
Subscribe To Our Newsletter & Stay Updated